J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit

Many top drugmakers have faced allegations that they offered free services as kickbacks to doctors, and Johnson & Johnson is confronting those claims in a newly unsealed whistleblower lawsuit.

In the suit, a former employee says J&J's Janssen unit helped doctors set up high-volume "infusion suites" and offered other services to amp up Remicade and Simponi prescriptions for more than a decade. Johnson & Johnson disclosed the suit in its annual Securities and Exchange Commission (SEC) filing, published Tuesday.